Join to view full profile
1919 Old Spanish TrailDuncan Cancer CenterHouston, TX 77054
Phone+1 832-957-6500
Fax+1 713-798-8884
Dr. Rimawi is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mothaffar Rimawi is an oncology specialist with a subspecialty in breast cancer, based in Houston, TX. He completed his medical education at the University of Jordan Faculty of Medicine, followed by extensive training at Baylor College of Medicine, where he also held several academic positions, including his current role as Professor and Executive Medical Director at the Dan L Duncan Comprehensive Cancer Center. Dr. Rimawi is experienced in chemotherapy, hormone therapy, monoclonal antibody tumor therapy, and clinical research, with numerous publications focusing on breast cancer treatment. He has been involved in clinical trials related to breast cancer therapies, and his accolades include being recognized as one of the Top Doctors in Southeast Texas.
Education & Training
Baylor College of MedicinePost-Doctoral Fellowship, 2003 - 2005- Baylor College of MedicineFellowship, Hematology and Medical Oncology, 2001 - 2004
- Baylor College of MedicineResidency, Internal Medicine, 1998 - 2001
University of Jordan Faculty of MedicineClass of 1997
Certifications & Licensure
TX State Medical License 2005 - 2028
IN State Medical License 2004 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2011, 2013-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011, 2013-2017
- Top Doctors:SE Texas Castle Connolly, 2013
Clinical Trials
Publications & Presentations
PubMed
- Systematic Evaluation of Data and Trial Fitness for Oncology Trial Emulation: Empirical Findings from the CARE Initiative.Natalie Levy, Paige Sheridan, Ulka Campbell, David Lenis, Inish O'Doherty
Clinical Pharmacology and Therapeutics. 2026-08-01 - VEMORA: Vaginal Estrogen versus non-hormonal MOisturizer in women Receiving Aromatase inhibitors: a randomized, controlled trial.Polly Niravath, Mothaffar Rimawi, Kai Sun, Hanh Mai, Akshjot Puri
Breast Cancer Research and Treatment. 2026-07-30 - Patient-reported outcomes from the TBCRC 022 study of neratinib and ado-trastuzumab emtansine for HER2-positive breast cancer brain metastases.Thomas Grinda, Hillary M Heiling, Nabihah Tayob, Karen L Smith, Raechel Davis
Breast. 2026-07-20
Journal Articles
- The Oral Selective Oestrogen Receptor Degrader (SERD) AZD9496 Is Comparable to Fulvestrant in Antagonising ER and Circumventing Endocrine ResistanceRinath Jeselsohn, Mothaffar F Rimawi, C Kent Osborne, Rachel Schiff, Nature
Press Mentions
Greenwich LifeSciences Provides Global Update on FLAMINGO-01April 3rd, 2025- This Blood Test Screens for 50 Different Types of Cancer. Is It Worth the $949 Price Tag?January 17th, 2025
- Greenwich LifeSciences Provides Year End UpdateDecember 29th, 2022
Professional Memberships
- Member
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
